Skip to Content
Glassware & Plasticware
Category Image
Laboratory Quality Control Solutions
Category Image

Liofilchem® Meropenem+Phenylboronic acid MR+BO, Antimicrobial Susceptibility Discs

(0 review)
SKU: 9176
Brand: Liofilchem
UoM: 250/pk
1,250.32 GH¢ 1,250.32 GH¢

Store Availability & Pickup
LabMart Limited - Tamale
NS-246, Via, 4388 Tamale-Kumbungu Rd, Tamale, Northern Region, Ghana
Not available
LabMart Limited
10 Rcecourse street, Accra, Greater Accra Region, Ghana
9 available
Add to cart
MOQ : 1.0 250/pk
Estimated delivery Estimated delivery: 3-5 business days
Telecel AirtelTigo Maestro Mastercard Visa MTN

The Liofilchem® Meropenem+Phenylboronic Acid (MR+BO) Antimicrobial Susceptibility Discs are designed to detect Klebsiella pneumoniae carbapenemase (KPC) production and other class A beta-lactamase activity in Gram-negative bacteria, including Enterobacterales. These discs combine Meropenem with Phenylboronic Acid (PBA), an inhibitor of KPC enzymes, for reliable detection of carbapenem-resistant strains due to KPC production.

Key Features

  1. Specific Detection:
    • Identifies KPC-producing bacteria by observing the synergistic effect of PBA in restoring meropenem activity.
  2. Dual Disc System:
    • Includes separate discs for Meropenem (MR) and Meropenem+Phenylboronic Acid (MR+BO) for comparative zone diameter analysis.
  3. Accurate Results:
    • A ≥5 mm increase in the zone of inhibition with MR+BO compared to MR alone confirms KPC activity.
  4. Ease of Use:
    • Compatible with the standardized disc diffusion method on Mueller-Hinton agar.
  5. Clinical Relevance:
    • Essential for guiding antimicrobial therapy in infections caused by carbapenem-resistant pathogens.

Applications

ApplicationDescription
Clinical DiagnosticsDetects KPC production in Gram-negative pathogens.
Antimicrobial Resistance StudiesMonitors the prevalence of KPC-producing bacteria in healthcare settings.
Pharmaceutical ResearchEvaluates carbapenem+PBA combination therapies against resistant strains.

Testing Procedure

  1. Preparation:
    • Prepare a bacterial suspension to 0.5 McFarland standard.
    • Spread the suspension uniformly on Mueller-Hinton agar plates.
  2. Application:
    • Place the Meropenem (MR) and Meropenem+PBA (MR+BO) discs on the agar surface using sterile forceps.
  3. Incubation:
    • Incubate plates at 35–37°C for 16–20 hours under aerobic conditions.
  4. Interpretation:
    • Measure and compare the zones of inhibition for both discs:
      • A zone diameter increase of ≥5 mm with MR+BO indicates KPC production.

Storage and Stability

ConditionTemperatureDuration
Long-Term Storage-20°CUntil expiration date
Short-Term Storage2–8°CUp to 2 weeks
During UseRoom TemperatureImmediate use only

Technical Specifications

FeatureDetails
Active ComponentsMeropenem (10 µg) and Meropenem+Phenylboronic Acid (10 µg + PBA)
Test MethodDisc diffusion
Compatible MediaMueller-Hinton agar
Incubation Conditions35–37°C for 16–20 hours
Target PathogensKPC-producing Gram-negative bacteria
Shelf LifeAs per expiration date on packaging
Pack Sizes50 or 100 discs per pack

Quality Control Data

Control OrganismExpected Results
Escherichia coli ATCC® 25922MR: ≥23 mm; MR+BO: Similar
Klebsiella pneumoniae (KPC-positive strain)MR: Reduced zone; MR+BO: Zone diameter increased by ≥5 mm
Pseudomonas aeruginosa ATCC® 27853MR: ≥18 mm; MR+BO: Similar
Staphylococcus aureus ATCC® 29213Not applicable (Gram-positive control)
  • Positive Controls: Confirm detection of KPC-producing strains.
  • Negative Controls: Ensure no false-positive results in non-KPC producers.

Interpretation of Results

Zone of Inhibition ComparisonInterpretation
MR zone = MR+BO zoneAbsence of KPC production.
MR zone ≥5 mm smaller than MR+BO zonePresence of KPC-producing bacteria.

Comparison with Other Disc-Based Tests

Test DiscRecommended Use
Meropenem+Phenylboronic Acid (MR+BO)Specific detection of KPC beta-lactamase producers.
Meropenem+EDTA (MR+ED)Detection of metallo-beta-lactamase (MBL) producers.
Meropenem+Cloxacillin (MR+CL)Detection of AmpC beta-lactamase producers.
Carbapenemase Combination DiscsGeneral detection of carbapenemase-mediated resistance.

Advantages

FeatureBenefit
Dual Testing SystemDifferentiates KPC resistance from other carbapenemases.
High Sensitivity and SpecificityReduces false-positive and false-negative results.
Ease of UseSimplified setup minimizes errors and time.
Standards ComplianceAdheres to global antimicrobial susceptibility testing guidelines.

Conclusion

The Liofilchem® Meropenem+Phenylboronic Acid (MR+BO) Antimicrobial Susceptibility Discs offer a reliable and precise method for detecting KPC-mediated carbapenem resistance in Gram-negative bacteria. Their high sensitivity, specificity, and adherence to international testing standards make them essential for diagnostic laboratories and resistance monitoring programs.

Application: Antimicrobial Resistance
Storage Temperature: -20°C
Product Type: Antibiotic Disc
Product Brand: Liofilchem
Product Grade: Microbiology grade

The Liofilchem® Meropenem+Phenylboronic Acid (MR+BO) Antimicrobial Susceptibility Discs are designed to detect Klebsiella pneumoniae carbapenemase (KPC) production and other class A beta-lactamase activity in Gram-negative bacteria, including Enterobacterales. These discs combine Meropenem with Phenylboronic Acid (PBA), an inhibitor of KPC enzymes, for reliable detection of carbapenem-resistant strains due to KPC production.

Key Features

  1. Specific Detection:
    • Identifies KPC-producing bacteria by observing the synergistic effect of PBA in restoring meropenem activity.
  2. Dual Disc System:
    • Includes separate discs for Meropenem (MR) and Meropenem+Phenylboronic Acid (MR+BO) for comparative zone diameter analysis.
  3. Accurate Results:
    • A ≥5 mm increase in the zone of inhibition with MR+BO compared to MR alone confirms KPC activity.
  4. Ease of Use:
    • Compatible with the standardized disc diffusion method on Mueller-Hinton agar.
  5. Clinical Relevance:
    • Essential for guiding antimicrobial therapy in infections caused by carbapenem-resistant pathogens.

Applications

ApplicationDescription
Clinical DiagnosticsDetects KPC production in Gram-negative pathogens.
Antimicrobial Resistance StudiesMonitors the prevalence of KPC-producing bacteria in healthcare settings.
Pharmaceutical ResearchEvaluates carbapenem+PBA combination therapies against resistant strains.

Testing Procedure

  1. Preparation:
    • Prepare a bacterial suspension to 0.5 McFarland standard.
    • Spread the suspension uniformly on Mueller-Hinton agar plates.
  2. Application:
    • Place the Meropenem (MR) and Meropenem+PBA (MR+BO) discs on the agar surface using sterile forceps.
  3. Incubation:
    • Incubate plates at 35–37°C for 16–20 hours under aerobic conditions.
  4. Interpretation:
    • Measure and compare the zones of inhibition for both discs:
      • A zone diameter increase of ≥5 mm with MR+BO indicates KPC production.

Storage and Stability

ConditionTemperatureDuration
Long-Term Storage-20°CUntil expiration date
Short-Term Storage2–8°CUp to 2 weeks
During UseRoom TemperatureImmediate use only

Technical Specifications

FeatureDetails
Active ComponentsMeropenem (10 µg) and Meropenem+Phenylboronic Acid (10 µg + PBA)
Test MethodDisc diffusion
Compatible MediaMueller-Hinton agar
Incubation Conditions35–37°C for 16–20 hours
Target PathogensKPC-producing Gram-negative bacteria
Shelf LifeAs per expiration date on packaging
Pack Sizes50 or 100 discs per pack

Quality Control Data

Control OrganismExpected Results
Escherichia coli ATCC® 25922MR: ≥23 mm; MR+BO: Similar
Klebsiella pneumoniae (KPC-positive strain)MR: Reduced zone; MR+BO: Zone diameter increased by ≥5 mm
Pseudomonas aeruginosa ATCC® 27853MR: ≥18 mm; MR+BO: Similar
Staphylococcus aureus ATCC® 29213Not applicable (Gram-positive control)
  • Positive Controls: Confirm detection of KPC-producing strains.
  • Negative Controls: Ensure no false-positive results in non-KPC producers.

Interpretation of Results

Zone of Inhibition ComparisonInterpretation
MR zone = MR+BO zoneAbsence of KPC production.
MR zone ≥5 mm smaller than MR+BO zonePresence of KPC-producing bacteria.

Comparison with Other Disc-Based Tests

Test DiscRecommended Use
Meropenem+Phenylboronic Acid (MR+BO)Specific detection of KPC beta-lactamase producers.
Meropenem+EDTA (MR+ED)Detection of metallo-beta-lactamase (MBL) producers.
Meropenem+Cloxacillin (MR+CL)Detection of AmpC beta-lactamase producers.
Carbapenemase Combination DiscsGeneral detection of carbapenemase-mediated resistance.

Advantages

FeatureBenefit
Dual Testing SystemDifferentiates KPC resistance from other carbapenemases.
High Sensitivity and SpecificityReduces false-positive and false-negative results.
Ease of UseSimplified setup minimizes errors and time.
Standards ComplianceAdheres to global antimicrobial susceptibility testing guidelines.

Conclusion

The Liofilchem® Meropenem+Phenylboronic Acid (MR+BO) Antimicrobial Susceptibility Discs offer a reliable and precise method for detecting KPC-mediated carbapenem resistance in Gram-negative bacteria. Their high sensitivity, specificity, and adherence to international testing standards make them essential for diagnostic laboratories and resistance monitoring programs.

No resources are currently available for this product.

This will display Shipping & Return.

The Liofilchem® Meropenem+Phenylboronic Acid (MR+BO) Antimicrobial Susceptibility Discs are designed to detect Klebsiella pneumoniae carbapenemase (KPC) production and other class A beta-lactamase activity in Gram-negative bacteria, including Enterobacterales. These discs combine Meropenem with Phenylboronic Acid (PBA), an inhibitor of KPC enzymes, for reliable detection of carbapenem-resistant strains due to KPC production.

Key Features

  1. Specific Detection:
    • Identifies KPC-producing bacteria by observing the synergistic effect of PBA in restoring meropenem activity.
  2. Dual Disc System:
    • Includes separate discs for Meropenem (MR) and Meropenem+Phenylboronic Acid (MR+BO) for comparative zone diameter analysis.
  3. Accurate Results:
    • A ≥5 mm increase in the zone of inhibition with MR+BO compared to MR alone confirms KPC activity.
  4. Ease of Use:
    • Compatible with the standardized disc diffusion method on Mueller-Hinton agar.
  5. Clinical Relevance:
    • Essential for guiding antimicrobial therapy in infections caused by carbapenem-resistant pathogens.

Applications

ApplicationDescription
Clinical DiagnosticsDetects KPC production in Gram-negative pathogens.
Antimicrobial Resistance StudiesMonitors the prevalence of KPC-producing bacteria in healthcare settings.
Pharmaceutical ResearchEvaluates carbapenem+PBA combination therapies against resistant strains.

Testing Procedure

  1. Preparation:
    • Prepare a bacterial suspension to 0.5 McFarland standard.
    • Spread the suspension uniformly on Mueller-Hinton agar plates.
  2. Application:
    • Place the Meropenem (MR) and Meropenem+PBA (MR+BO) discs on the agar surface using sterile forceps.
  3. Incubation:
    • Incubate plates at 35–37°C for 16–20 hours under aerobic conditions.
  4. Interpretation:
    • Measure and compare the zones of inhibition for both discs:
      • A zone diameter increase of ≥5 mm with MR+BO indicates KPC production.

Storage and Stability

ConditionTemperatureDuration
Long-Term Storage-20°CUntil expiration date
Short-Term Storage2–8°CUp to 2 weeks
During UseRoom TemperatureImmediate use only

Technical Specifications

FeatureDetails
Active ComponentsMeropenem (10 µg) and Meropenem+Phenylboronic Acid (10 µg + PBA)
Test MethodDisc diffusion
Compatible MediaMueller-Hinton agar
Incubation Conditions35–37°C for 16–20 hours
Target PathogensKPC-producing Gram-negative bacteria
Shelf LifeAs per expiration date on packaging
Pack Sizes50 or 100 discs per pack

Quality Control Data

Control OrganismExpected Results
Escherichia coli ATCC® 25922MR: ≥23 mm; MR+BO: Similar
Klebsiella pneumoniae (KPC-positive strain)MR: Reduced zone; MR+BO: Zone diameter increased by ≥5 mm
Pseudomonas aeruginosa ATCC® 27853MR: ≥18 mm; MR+BO: Similar
Staphylococcus aureus ATCC® 29213Not applicable (Gram-positive control)
  • Positive Controls: Confirm detection of KPC-producing strains.
  • Negative Controls: Ensure no false-positive results in non-KPC producers.

Interpretation of Results

Zone of Inhibition ComparisonInterpretation
MR zone = MR+BO zoneAbsence of KPC production.
MR zone ≥5 mm smaller than MR+BO zonePresence of KPC-producing bacteria.

Comparison with Other Disc-Based Tests

Test DiscRecommended Use
Meropenem+Phenylboronic Acid (MR+BO)Specific detection of KPC beta-lactamase producers.
Meropenem+EDTA (MR+ED)Detection of metallo-beta-lactamase (MBL) producers.
Meropenem+Cloxacillin (MR+CL)Detection of AmpC beta-lactamase producers.
Carbapenemase Combination DiscsGeneral detection of carbapenemase-mediated resistance.

Advantages

FeatureBenefit
Dual Testing SystemDifferentiates KPC resistance from other carbapenemases.
High Sensitivity and SpecificityReduces false-positive and false-negative results.
Ease of UseSimplified setup minimizes errors and time.
Standards ComplianceAdheres to global antimicrobial susceptibility testing guidelines.

Conclusion

The Liofilchem® Meropenem+Phenylboronic Acid (MR+BO) Antimicrobial Susceptibility Discs offer a reliable and precise method for detecting KPC-mediated carbapenem resistance in Gram-negative bacteria. Their high sensitivity, specificity, and adherence to international testing standards make them essential for diagnostic laboratories and resistance monitoring programs.

No resources are currently available for this product.

This will display Shipping & Return.